G-BA says Sativex offers 'marginal' additional benefit

Germany's Federal Joint Committee (G-BA) said Sativex from GW Pharmaceuticals plc (LSE:GWP) provides a "marginal" degree of additional benefit over optimized standard therapy to treat spasticity in mu...